Form 4: Azenta Inc. Executive Zhou Ginger Reports Acquisition of Restricted Stock Units

SVP and General Manager of Genom at Azenta, Inc., Zhou Ginger, reports the acquisition of 6,333 restricted stock units at a price of $55.27 on August 9, 2024.

Summary

• On August 9, 2024, Zhou Ginger, SVP and General Manager of Genom at Azenta, Inc., acquired 6,333 restricted stock units.
• The price of the transaction was $55.27 per unit.
• These units were granted under the company's Equity Incentive Plan.
• The restricted stock units will vest over two years, with 50% vesting on August 9, 2025, and the remaining 50% vesting on August 9, 2026.
• Following the reported transaction, Zhou Ginger beneficially owns 19,339 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management interests with shareholders. There are no indications of negative events or concerns.

Positives

• The grant of restricted stock units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and contribution to Azenta's success.

Future Outlook

The vesting schedule of the restricted stock units suggests an expectation of continued employment and contribution from Zhou Ginger over the next two years.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies to align management's interests with shareholders.

Stakeholder Impact

• The grant of restricted stock units aligns the executive's interests with those of the shareholders, potentially leading to better company performance.

Key Dates